Medical marijuana advocates have long criticized New Jersey's program, saying it was much too small. Roughly 18,000 patients are enrolled in the state's program, compared to around 220,000 patients in Michigan, a similarly sized state.
"It was a program designed to keep people out of it," said Ken Wolski, CEO of the Coalition for Medical Marijuana New Jersey, shorly after Murphy announced the audit. "It's a program that's not meeting the needs of the patients."